Gastric Cancer: Chemotherapy for Advanced Disease with Special Focus on Studies from Japan

2018 ◽  
pp. 173-180
Author(s):  
Taroh Satoh
Keyword(s):  
Gastric Cancer ◽  
Cancer Chemotherapy ◽  
Advanced Disease ◽  
Special Focus

Gastric cancer: Chemotherapy of advanced disease

1992 ◽  
Vol 10 (1) ◽  
pp. 37-42 ◽  
Author(s):  
John S. Macdonald
Keyword(s):  
Gastric Cancer ◽  
Cancer Chemotherapy ◽  
Advanced Disease

Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapy

2009 ◽  
Vol 61 (5) ◽  
pp. 402-407 ◽  
Author(s):  
Masahiko Nishiyama ◽  
Hidetaka Eguchi
Keyword(s):  
Gastric Cancer ◽  
Cancer Chemotherapy

scholarly journals PERIOPERATIVE CHEMOTHERAPY IN LOCALLY ADVANCED GASTRIC CANCER

2013 ◽  
Vol 50 (3) ◽  
pp. 236-242 ◽  
Author(s):  
Thales Paulo BATISTA ◽  
Candice Amorim de Araujo Lima SANTOS ◽  
Gustavo Fernandes Godoy ALMEIDA
Keyword(s):  
Gastric Cancer ◽  
Therapeutic Strategy ◽  
Multimodal Therapy ◽  
Standard Treatment ◽  
Treatment Options ◽  
Locally Advanced ◽  
Special Focus ◽  
Perioperative Chemotherapy ◽  
Locally Advanced Gastric Cancer ◽  
Advanced Stages

Gastric cancer is one of the most common cancers and a main cause of cancer-related death worldwide, since the majority of patients suffering of this malignancy are usually faced with a poor prognosis due to diagnosis at later stages. In order to improve treatment outcomes, the association of surgery with chemo and/or radiotherapy (multimodal therapy) has become the standard treatment for locally advanced stages. However, despite several treatment options currently available for management of these tumors, perioperative chemotherapy has been mainly accepted for the comprehensive therapeutic strategy including an appropriated D2-gastrectomy. This manuscript presents a (nonsystematic) critical review about the use of perioperative chemotherapy, with a special focus on the drugs delivery.

scholarly journals Chemotherapy of disseminated gastric cancer. A joint effort of the Northern California oncology group and the Japanese gastric cancer chemotherapy group

Cancer ◽  
1983 ◽  
Vol 52 (10) ◽  
pp. 1771-1777 ◽  
Author(s):  
Michael A. Friedman ◽  
Makoto Ogawa ◽  
Stephen K. Carter ◽  
Yoshio Sakurai ◽  
Kioji Kimura ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Cancer Chemotherapy ◽  
Northern California ◽  
Oncology Group ◽  
Joint Effort ◽  
Chemotherapy Group

Acid‐Responsive H2‐Releasing 2D MgB2Nanosheet for Therapeutic Synergy and Side Effect Attenuation of Gastric Cancer Chemotherapy

2019 ◽  
Vol 8 (13) ◽  
pp. 1900157 ◽  
Author(s):  
Mingjian Fan ◽  
Yanyuan Wen ◽  
Dien Ye ◽  
Zhaokui Jin ◽  
Penghe Zhao ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Cancer Chemotherapy ◽  
Side Effect

scholarly journals Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy

2015 ◽  
Vol 2015 ◽  
pp. 1-14 ◽  
Author(s):  
Vinod Vijay Subhash ◽  
Mei Shi Yeo ◽  
Woei Loon Tan ◽  
Wei Peng Yong
Keyword(s):  
Gastric Cancer ◽  
Immune System ◽  
Cancer Immunotherapy ◽  
Cancer Biology ◽  
Tumor Regression ◽  
Treatment Options ◽  
Special Focus ◽  
Tumor Type ◽  
Cell Therapies ◽  
Gastric Cancer Treatment

In cancer biology, cells and molecules that form the fundamental components of the tumor microenvironment play a major role in tumor initiation, and progression as well as responses to therapy. Therapeutic approaches that would enable and harness the immune system to target tumor cells mark the future of anticancer therapy as it could induce an immunological memory specific to the tumor type and further enhance tumor regression and relapse-free survival in cancer patients. Gastric cancer is one of the leading causes of cancer-related mortalities that has a modest survival benefit from existing treatment options. The advent of immunotherapy presents us with new approaches in gastric cancer treatment where adaptive cell therapies, cancer vaccines, and antibody therapies have all been used with promising outcomes. In this paper, we review the current advances and prospects in the gastric cancer immunotherapy. Special focus is laid on new strategies and clinical trials that attempt to enhance the efficacy of various immunotherapeutic modalities in gastric cancer.

scholarly journals IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance

2015 ◽  
Vol 33 (6) ◽  
pp. 2746-2752 ◽  
Author(s):  
XIAO-LEI YE ◽  
YA-RONG ZHAO ◽  
GUO-BIN WENG ◽  
YI-CHEN CHEN ◽  
XUE-NI WEI ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Cancer Chemotherapy ◽  
Chemotherapy Resistance ◽  
Jnk Pathway ◽  
Pathway Activation

scholarly journals Adjuvant Treatment for Gastric Cancer: Chemotherapy Versus Radiation

2013 ◽  
Vol 18 (9) ◽  
pp. 1013-1021 ◽  
Author(s):  
Noman Ashraf ◽  
Sarah Hoffe ◽  
Richard Kim
Keyword(s):  
Gastric Cancer ◽  
Cancer Chemotherapy ◽  
Adjuvant Treatment

scholarly journals 4. Current Status of Gastric Cancer Chemotherapy

2017 ◽  
Vol 106 (Suppl) ◽  
pp. 123b-123b
Author(s):  
Kensei Yamaguchi
Keyword(s):  
Gastric Cancer ◽  
Cancer Chemotherapy ◽  
Current Status
Sign in / Sign up

Export Citation Format

Share Document